IceCure Seeks Authority for Up to 40-for-1 Reverse Split to Hold Nasdaq Listing
ICCM is trading near its 52-week low of $0.82 (2.8% above the low) on light trading volume (0.3× avg).
Summary
At the November 19, 2026 meeting, IceCure will ask shareholders to authorize one or more reverse splits of 5-for-1 up to a cumulative 40-for-1 within 24 months, aimed at restoring compliance with Nasdaq's $1.00 minimum bid price.
Key Events · Corporate Governance and Compliance · ICCM
-
Reverse Split Authorization Requested
On November 1, 2026, the board approved the framework and now asks shareholders to authorize one or more reverse splits at not less than 5-for-1, cumulative cap 40-for-1, within 24 months of the meeting.
-
Nasdaq Minimum Bid Compliance
The stated purpose is maintaining compliance with Nasdaq Listing Rule 5550(a)(2), which requires a $1.00 minimum bid price; the stock closed at $0.8428.
-
Authorized Shares Stay at 2.5 Billion
The reverse split will not reduce the 2,500,000,000 authorized Ordinary Shares, leaving large unissued capacity for future financing and dilution.
-
Vote Set for November 19, 2026
A Special General Meeting will be held on November 19, 2026 at 10:00 a.m. Israel time, with a record date of November 4, 2026; a simple majority of votes cast is required, and because the proposal is not a routine matter, broker non-votes will occur without instructions.
Analysis · ICCM · Industrial Applications And Services
The board wants a 24-month option to reverse-split the stock by anywhere from 5-for-1 up to a cumulative 40-for-1, purely to get the share price back above Nasdaq's $1.00 minimum bid. With the stock at $0.8428, below that threshold, a delisting notice is a live risk and this is the company's remedy. A reverse split does not change anyone's percentage ownership, but it usually reads as distress and it shrinks the share count while leaving 2.5 billion authorized shares in place — capacity the company can later use to issue stock, which is real future dilution risk. The vote is November 19, 2026, with a November 4 record date; approval is by simple majority of votes cast.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ICCM was trading at $0.84 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.9M. The 52-week trading range was $0.82 to $23.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.